Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM ANHYDROUS vs METFORMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM ANHYDROUS vs METFORMIN: Safety Overview

Metric MEROPENEM ANHYDROUS METFORMIN
Total FAERS Reports 144 90,968
Deaths Reported 25 11,550
Death Rate 17.4% 12.7%
Hospitalizations 102 40,702
Average Patient Age 55.0 yrs 61.9 yrs
% Female Patients 44.2% 54.3%
FDA Approval Date N/A Apr 11, 2003
Manufacturer Mylan Institutional LLC A-S Medication Solutions
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued